Upload
doctor
View
58
Download
0
Embed Size (px)
DESCRIPTION
Perturbation of fetal liver haematopoietic stem and progenitor cell development by trisomy 21. Anindita Roy Imperial College London. Leukaemia in children with Down syndrome (DS). Hasle, 2008. Acute leukaemias in Down syndrome. Birth. TAM. DS AMKL. +21. 20-30%. +21 GATA1s Gene X. +21 - PowerPoint PPT Presentation
Citation preview
Perturbation of fetal liver haematopoietic stem and progenitor cell development by
trisomy 21
Anindita RoyImperial College London
Leukaemia in children with Down syndrome (DS)
Condition Frequency observed in population
Frequency observed in DS
Excess risk in DS
Acuteleukaemia
1 in 2800 1 in 100-200 10-20 x
ALL 1 in 3500 1 in 300 12 x
AML 1 in 14 000 1 in 300 46 x
AMKL 1 in 233 000 1 in 500 466 x
Hasle, 2008
TAM+21
+21GATA1sGene X
DS AMKL
Acute leukaemias in Down syndrome
+21GATA1s
+21
Birth
Fetalhaematopoietic
cell
DS ALL
+21JAK2R683
CRLF2 m
What is the role of trisomy 21 and how does it perturb fetal haematopoiesis in Down syndrome?
+21? CRLF2
+21CRLF2CRLF2 m
20-30%
Role of trisomy 21 in fetal haematopoiesis
Aim 1:Characterise 2nd trimester normal and T21 human fetal liver (FL) haematopoiesis
Aim 2:Study in vitro behaviour of normal and T21 FL HSC and progenitors.
Aim 3:Define gene expression signature of normal vs T21 FL HSC and progenitors
Fetal Haematopoiesis: Principal Progenitor Populations
LMPP
CD34+
CD38+CD38-
Perturbation of fetal liver HSC/progenitor frequency in DS
CBP
CBP
Perturbation of fetal liver B progenitor frequency in DS
N FL
T21 FL
CD34+CD19+ B progenitors were significantly reduced in DS FL, especially CD34+CD19+CD10- Pre pro B cells
Normal
Perturbation of fetal liver HSC/progenitor frequency in DS
Analysis of fetal liver HSC/progenitors
Flow sorted progenitors
HSC MPP LMPP
1) Methylcellulose clonogenic assays (100)
2) Lymphoid stromal co cultures (100)
3) Gene expression (Fluidigm-qRT PCR) (50)
4) Xenograft studies (1000- 30,000)
Analysis done (no. of cells used/ population)
CD
14/1
5/16
Clonogenic assays of FL progenitors
Colony readout after 14 days of clonogenic assay of FL HSC/ progenitors
Increased clonogenicity of progenitors in DS FL
In vitro clonogenic assays showed significantly increased clonogenicity of T21 HSC,CMP and MEP compared to normal FL
Increased megakaryocyte/erythroid potential of HSC/progenitors in DS
0
10
20
30
40
50
60
70
80
HSC MPP LMPP CMP MEP GMP
No.
of c
olon
ies/
100
cel
ls p
late
d
CFU-GEMMERYTHROIDCFU-MkECFU-MkCFU-G/M/GMMYELOID BLAST
0
10
20
30
40
50
60
70
80
HSC MPP LMPP CMP MEP GMP
No.
of c
olon
ies/
100
cel
ls p
late
d
NORMAL
DOWN SYNDROME
CO
LON
IES/
100
CEL
LS
Impaired B cell differentiation of DS FL progenitors
DS FL HSC, LMPP and ELP did not produce CD34-19+ B cells in MS5 co cultures
N
T21
CD
19
NSG mouse engraftment model
200 cGy CD34 + cells (1000- 30,000)
Terminate expt at 12 weeks. Analysis of BM, spleen, thymus and liver for human immature and mature haematopoietic cells
Qualitative differences in engraftment of normal vs. DS FL CD34 cells in the bone marrow of NSG mice
N
T21
LYMPHOID MK/Ery
Further characterisation of engrafted hCD45 cells
DS FL CD34 cells demonstrate reduced (lymphoid) engraftment in NSG mice suggesting cell intrinsic abnormalities caused by T21
Altered gene expression in DS FL HSC/ progenitorsLYMPHOID GENES MEGA-ERYTHROID MYELOID GENES
1. Demonstrated HSC, MPP and LMPP for the first time in human FL
2. Demonstrated lymphoid progenitors and mature B cells in human FL for the first time (including novel CD34+CD19+CD10- progenitor which may be key to understanding pathogenesis of childhood ALL) and showed that mature B cells can be generated in vitro
3. Comprehensive gene expression analysis of normal FL HSC and progenitors.
Summary: defining normal FL haematopoiesis
Abnormal fetal liver haematopoiesis in DS
ELPLMPP
HSC GMPMPP
MEP
B PROG
T PROG
Differences in gene priming determinelineage decisions
B PROG
AcknowledgmentsProf Irene RobertsTassos Karadimitris
Gillian CowanSarah FilippiGeorg BohnKaterina GoudevenouAris ChaidosMing HuLuciana GarguiloSubarna ChakravortyKate XuValentina CaputoMauritius KleijnenKelly MakaronaDavid O’ConnorJoanna CostaSuhail ChaudhuryRebecca Babb
Ollie Tustall-Pedoe
Prof Phillip BennettHikoro Matsui
Philip HexleyEugene NgJames ElliottValeria Melo
Oxford:Paresh Vyas Adam Mead Debbie AtkinsonSE Jacobsen
Manchester:Vaskar Saha
Singapore:Jerry ChanCitra Mater
Thank you
Chr 21 gene expression in DS FL HSC/ progenitors
•
1. Xenograft data for HSC compartment (may need better mouse model than NSG for mega-erythroid engraftment)
2. Explore significance of microenvironment in more detail (FL vs FBM)
3. Lymphoid defect: -RAG1 (overexpression: ? B lymphoid block/ DNA damage)-functional studies with mature B cells-Fetal BM lymphoid development in more detail
4. Explore cytokine receptor pathways such as IGF1R and IGF2R
Future research directions
EBF1 NETWORK
EBF1
E2A
IL7R
PU.1 lo
PAX5
CD79aVPREB
CEBPa
FLT3
GATA1
FOR MYELOID FATE
ERYTHROID FATE
NOTCH1
T CELL FATE
PROPOSED B CELL PATHWAY
MPP
LMPP
ELP
BP
E2A
EBF1
EBF1PAX5
IL7R
FLT3
GATA1 (loss or mega erythroid potential)
PU.1CEBPa
(loss or myeloid potential)
NOTCH1 (loss or T potential)
KEY: ELP: early lymphoid progenitor; BP: B cell progenitor